As compared to other parts of the population, minorities in the US are disproportionately affected by COVID-19. Yet, minority patients remain underrepresented in COVID-19 clinical trials.
This webinar takes a closer look at the current COVID-19 clinical trial landscape and whether ongoing trials properly reflect the demographic profile of the affected population. Panelists will discuss barriers to the inclusion of diverse populations as well as current strategies to encourage trial participation by minorities during the pandemic.
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.